Answers are grounded in this paper and cite their sources.
Background: Cervical cancer remains one of the major public health challenges worldwide. Persistent infection with high-risk human papillomavirus (HPV) is recognized as the principal etiological factor in the development of cervical precancerous lesions and cervical cancer. Early detection of these lesions is essential for preventing disease progression and reducing cervical cancer-related mortality. Objective: This article aims to evaluate the importance of cytological and molecular-genetic laboratory diagnostic methods in the early detection of cervical precancerous lesions and to highlight their complementary role in modern cervical cancer screening programs. Methods: A narrative review of scientific literature and international clinical guidelines was conducted, focusing on conventional cervical cytology, liquid-based cytology, HPV DNA testing, polymerase chain reaction (PCR), HPV genotyping, and immunocytochemical biomarkers. Results: Cytological examination, particularly the Papanicolaou (Pap) test, remains an important method for identifying morphological abnormalities in cervical epithelial cells. Molecular-genetic techniques provide additional information by detecting high-risk HPV infections, including HPV genotypes 16 and 18, which are strongly associated with cervical carcinogenesis. The combination of cytological and molecular-genetic approaches improves risk assessment and supports the identification of women who require further diagnostic evaluation. Emerging methods, including p16/Ki-67 dual-stain cytology, provide additional opportunities for identifying transforming HPV infections. Conclusion: The integration of cytological and molecular-genetic laboratory diagnostics plays a significant role in the early detection of cervical precancerous lesions. A combined diagnostic approach can improve screening effectiveness, facilitate timely clinical intervention, and contribute to the prevention of invasive cervical cancer.
No takes yet. Share an insight, caveat, or question.
Azizbek Akramjon o'g'li A'zamjonov (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: